Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medacta GroupLTS:0A05 +2.49%89 Days Inventory is 424.37 as of Dec. 2025, which is 1% below its 10-year median of 428.83. GuruFocus rates LTS:0A05 with a GF Score™ of 89/100 and a GF Value™ of CHF168.11 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 787 Medical Devices & Instruments companies, Medacta Group ranks worse than 87.04% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Medacta Group's Average Total Inventories for the
six
months ended in Dec. 2025 was CHF252.0 Mil. Medacta Group's Cost of Goods Sold for the
six
months ended in Dec. 2025 was CHF108.4 Mil.
Hence, Medacta Group's Days Inventory for the
six
months ended in Dec. 2025 was 424.37.
The historical rank and industry rank for Medacta Group's Days Inventory or its related term are showing as below:
LTS:0A05'
s Days Inventory Range Over the Past 10 Years
Min: 395.44 Med: 428.83 Max: 456.22
Current: 417.55
During the past 11 years, Medacta Group's highest Days Inventory was 456.22. The lowest was 395.44. And the median was 428.83.
LTS:0A05's Days Inventory is ranked worse than 87.04% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 179.47
vs LTS:0A05: 417.55
Medacta Group's Days Inventory
increased
from Dec. 2024 (423.79) to Dec. 2025 (424.37).
It might indicate that Medacta Group's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Medacta Group's Inventory Turnover for the
six
months ended in Dec. 2025 was 0.43.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Medacta Group's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.80.
Medacta Group (LTS:0A05) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Medacta Group's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Medacta Group's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Medacta Group Days Inventory Related Terms
Medacta Group Days Inventory Historical Data
* Premium members only.
The historical data trend for Medacta Group's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0A05 vs ABT, SYK, MDT: Days Inventory Comparison
For the Medical Devices subindustry, Medacta Group's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medacta Group Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medacta Group's Days Inventory distribution charts can be found below:
* The bar in red indicates where Medacta Group's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medacta Group (LTS:0A05) has a Days Inventory of 424.37 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Medacta Group and its competitors. This is near median its historical median of 428.83. Over the past decade, Medacta Group's Days Inventory has ranged from 395.44 to 456.22. According to the industry distribution chart, Medacta Group ranks #685 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 87%.
Is Medacta Group's Days Inventory too high?
Medacta Group's current Days Inventory of 424.37 is near median its 10-year median of 428.83. Over the past 10 years, this metric has ranged from a low of 395.44 to a high of 456.22. The Medical Devices & Instruments industry median Days Inventory is 179.47. Medacta Group's value of 424.37 is 136.5% above this industry median. Based on the distribution chart, Medacta Group ranks #685 out of 787 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Medacta Group has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medacta Group's Days Inventory compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medacta Group ranks #685 out of 787 companies for Days Inventory. This places Medacta Group in the lower half of its industry. The industry median Days Inventory is 179.47. Medacta Group's value of 424.37 is 136.5% above this benchmark. Historically, Medacta Group's own Days Inventory has ranged from 395.44 to 456.22 over the past decade. While the company's 10-year median is 428.83 vs. the industry median of 179.47, Medacta Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.47, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medacta Group's current Days Inventory of 424.37 is 136.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Medacta Group and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medacta Group's current Days Inventory is 424.37, which is near median its own 10-year median of 428.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medacta Group stock overvalued right now?
Based on GuruFocus' analysis, Medacta Group (LTS:0A05) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF168.11, compared to a current price of CHF139.80 — trading 16.8% below its estimated fair value. The current Days Inventory is 424.37, which is near median its 10-year median of 428.83 and 136.5% above the Medical Devices & Instruments industry median of 179.47. Medacta Group's overall GF Score™ is 89/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Medacta Group (LTS:0A05), the current Days Inventory is 424.37 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medacta Group (LTS:0A05) Overvalued in 2026?
Based on GuruFocus' analysis, Medacta Group stock appears to be undervalued.
The current stock price of CHF139.80 is trading 16.8% below its estimated GF Value™ of CHF168.11.
GuruFocus considers Medacta Group to be Modestly Undervalued.
Key valuation signals for LTS:0A05:
Days Inventory: 424.37 (near median its 10-year median of 428.83)
GF Value™: CHF168.11 vs. price of CHF139.80 (16.8% below fair value)
Industry Position: 136.5% above the Medical Devices & Instruments median (#685 of 787)
No single metric tells the full story. See the LTS:0A05 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medacta Group SA is involved in developing, manufacturing, and distributing orthopedic and neurosurgical medical devices. It specializes in the design, production, and distribution of personalized and sustainable solutions for joint replacement, sports medicine, and spine surgery. Medacta's product portfolio includes hip, knee, shoulder, and spine replacement solutions, along with a comprehensive range of sports medicine. Its products and surgical techniques are supported by an extensive program of surgeon education and engagement initiatives, enabling its offerings to be effective for the patient and surgeon. Geographically, the company derives maximum revenue from EMEA (which includes Europe, Middle East and Africa), followed by North America, Asia-Pacific, and the Latin America markets.
89GF Score
Get the complete analysis for LTS:0A05
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0A05 has been successfully added to your 
